Edges in Network
| Network | GSE32269_top8000 - GSE32269 - SiGN-BN NNSR |
| Network Description | Expression data for primary localized prostate cancer versus castration-resistant bone metastatic prostate cancer |
| Node | CYP2C9 |
| Upstream (Parents) |
|---|
| (<<) FANCC → CYP2C9 |
| (<<) SLC17A1 → CYP2C9 |
| (<<) TTPA → CYP2C9 |
| (<<) TP53TG3B///TP53TG3 → CYP2C9 |
| (<<) ASF1A → CYP2C9 |
| (<<) OR10H3 → CYP2C9 |
| (<<) ACRV1 → CYP2C9 |
| Downstream (Children) |
|---|
| CYP2C9 → FAM63A (>>) |
| CYP2C9 → KIR2DL1 (>>) |
| CYP2C9 → CACNB2 (>>) |
| CYP2C9 → DEC1 (>>) |
| CYP2C9 → ZC3HAV1 (>>) |
| CYP2C9 → IQSEC1 (>>) |
| CYP2C9 → BRAP (>>) |
| CYP2C9 → PHLPP2 (>>) |
| CYP2C9 → PRKRIP1 (>>) |
| CYP2C9 → TNFSF13 (>>) |
| CYP2C9 → ADAM23 (>>) |
| CYP2C9 → ADAMTS6 (>>) |
| CYP2C9 → CD207 (>>) |
| CYP2C9 → GK2 (>>) |
| CYP2C9 → FOXA2 (>>) |
| CYP2C9 → ADAMTS13 (>>) |
| CYP2C9 → ASF1A (>>) |
| CYP2C9 → MED31 (>>) |
| CYP2C9 → KRT35 (>>) |
| CYP2C9 → TRIP6 (>>) |
| CYP2C9 → ZBED2 (>>) |
| CYP2C9 → PRPH (>>) |
| CYP2C9 → DOCK5 (>>) |
| CYP2C9 → PCDHB17 (>>) |
| CYP2C9 → CYP2C19 (>>) |
